• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Editorial Concerning "Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy".关于“前列腺尿路上皮癌累及程度对根治性膀胱切除术后生存的影响”的社论
Bladder Cancer. 2017 Jul 27;3(3):171-172. doi: 10.3233/BLC-179017.
2
Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens.膀胱尿路上皮癌患者的偶发前列腺癌：1476 例根治性膀胱前列腺切除术标本的综合分析。
J Urol. 2013 Nov;190(5):1704-9. doi: 10.1016/j.juro.2013.05.034. Epub 2013 May 23.
3
Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy.前列腺尿路上皮癌累及程度对根治性膀胱切除术后生存的影响。
Bladder Cancer. 2017 Jul 27;3(3):161-169. doi: 10.3233/BLC-160086.
4
Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy.前列腺累及尿路上皮癌：肿瘤分期修订和合并膀胱癌与根治性膀胱切除术生存的相关性。
BJU Int. 2014 Dec;114(6):832-6. doi: 10.1111/bju.12486.
5
[Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice].[膀胱癌患者中尿路上皮癌的前列腺受累情况及其在临床实践中的意义]
Actas Urol Esp. 2012 Oct;36(9):545-53. doi: 10.1016/j.acuro.2012.02.005. Epub 2012 Apr 19.
6
Assessing the Impact of Time to Cystectomy for Variant Histology of Urothelial Bladder Cancer.评估膀胱癌变异组织学行膀胱切除术时间的影响。
Urology. 2019 Nov;133:157-163. doi: 10.1016/j.urology.2019.07.034. Epub 2019 Aug 14.
7
Natural history of positive urinary cytology after radical cystectomy.根治性膀胱切除术后尿细胞学阳性的自然病程。
J Urol. 2006 Nov;176(5):2000-5; discussion 2005. doi: 10.1016/j.juro.2006.07.049.
8
Implications of Definitive Prostate Cancer Therapy on Soft Tissue Margins and Survival in Patients Undergoing Radical Cystectomy for Bladder Urothelial Cancer.根治性前列腺癌治疗对接受膀胱尿路上皮癌根治性膀胱切除术患者软组织切缘及生存的影响。
J Urol. 2015 Nov;194(5):1220-5. doi: 10.1016/j.juro.2015.05.091. Epub 2015 Jun 6.
9
The impact of histological reclassification during pathology re-review--evidence of a Will Rogers effect in bladder cancer?病理复查过程中组织学分型再分类的影响——膀胱癌中的威尔·罗杰斯效应证据？
J Urol. 2013 Nov;190(5):1692-6. doi: 10.1016/j.juro.2013.05.040. Epub 2013 May 23.
10
The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.鳞状和腺体分化对膀胱癌根治性膀胱切除术后生存的影响。
J Urol. 2012 Aug;188(2):405-9. doi: 10.1016/j.juro.2012.04.020. Epub 2012 Jun 14.

本文引用的文献

1
Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy.前列腺尿路上皮癌累及程度对根治性膀胱切除术后生存的影响。
Bladder Cancer. 2017 Jul 27;3(3):161-169. doi: 10.3233/BLC-160086.
2
Outcomes of patients undergoing radical cystoprostatectomy for bladder cancer with prostatic involvement on final pathology.膀胱癌伴前列腺受累患者接受根治性膀胱前列腺切除术的最终病理结果。
BJU Int. 2009 Oct;104(8):1091-7. doi: 10.1111/j.1464-410X.2009.08558.x. Epub 2009 Apr 15.
3
Prostatic transitional cell carcinoma: pathologic features and clinical management.前列腺移行细胞癌：病理特征与临床管理
Expert Rev Anticancer Ther. 2007 Aug;7(8):1155-62. doi: 10.1586/14737140.7.8.1155.
4
Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy.接受根治性膀胱前列腺切除术患者前列腺病变的风险评估
Eur Urol. 2008 Feb;53(2):370-5. doi: 10.1016/j.eururo.2007.07.031. Epub 2007 Jul 26.

Editorial Concerning "Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy".

作者信息

Shen Steven, Lerner Seth P

机构信息

Professor of Pathology and Laboratory Medicine, Associate Director of Surgical Pathology, Department of Pathology and Genomic Medicine, Houston Methodist Hospital and Weill Medical College of Cornell University.

Professor and Beth and Dave Swalm Chair in Urologic Oncology, Director of Urologic Oncology, Scott Department of Urology, Baylor College of Medicine.

出版信息

Bladder Cancer. 2017 Jul 27;3(3):171-172. doi: 10.3233/BLC-179017.

DOI:10.3233/BLC-179017
PMID:28824944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5545913/
Abstract
摘要